Adma Biologics Inc (ADMA)

R&D Expenses

$6.01M

Quarterly · Period ending: · USD

ADMA logo

ADMA R&D Expenses

Latest reported$6.01M
ADMA Quarterly R&D Expenses ($0.00 → $6.01M)
High-resolution chart · PNG

ADMA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
6,014,000
2,597,000
1,376,000
1,528,000
1,031,000
826,000
391,000
412,000
560,000
450,000
445,486
596,000
1,403,000
855,000
1,074,320
1,041,947
873,386
624,111
728,988
770,557
1,158,866
987,649
1,013,464
1,708,391
1,656,420
1,528,738
464,823
491,404
516,986
870,635
-144,920
1,317,234
1,472,100
1,281,706
1,864,382
1,814,069
1,358,409
1,192,727
583,374
1,677,263
3,399,889
2,027,712
1,996,808
2,111,505
1,505,909
1,401,723
1,919,719
1,482,929
1,783,909
4,330,457
2,956,153
1,408,990
3,470,350
1,467,584
1,267,947
1,940,637
178,674
81,820
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.